Columbia University

Technology Ventures

Featured Funding Opportunities

In support of its mission to facilitate the transfer of inventions from academic research labs to the market, CTV publicizes funding opportunities that may be relevant to Columbia inventors as they conduct research and develop new technologies. For additional lists of funding opportunities, refer to these resources:

For further assistance with grant applications, see CTV's collection of IP and Entrepreneurship Language for Grant Applications.

Past Funding Opportunities

right

2023 Herbert Irving Comprehensive Cancer Center Irving Cancer Drug Discovery Program

Deadline: 
Wednesday, February 15, 2023 - 5:00pm

 

 

right

CSL Research Acceleration Initiative 2023

Deadline: 
Thursday, February 23, 2023 - 5:00pm

CSL is a leading global biotech company that develops and delivers innovative biotherapies to help people living with life-threatening medical conditions live full lives.

CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations. These partnerships provide funding and access to industry experts for scientists working on novel biotherapeutic strategies in CSL’s therapeutic areas.

right

Women Scientists Innovation Award for Cancer Research

Deadline: 
Monday, February 6, 2023 - 5:00pm

 

 

PURPOSE OF AWARD: The pandemic has been a setback for the careers of researchers, particularly women. Sustaining the careers of women in research and preventing the loss of women from academic careers focused on cancer is paramount to accomplishing the V Foundation’s mission. To help level the playing field for women in cancer research, we propose the V Foundation’s “Women Scientists Innovation Award for Cancer Research.”

right

XSeed Award

Deadline: 
Monday, January 16, 2023 - 5:00pm

 

 

Deerfield Management Company, a New York City-based healthcare investment firm and Advancium Health Network, a public charity dedicated to advancing healthcare services and health equity through philanthropic investment, are accepting applications for the third annual XSeed Award, a program designed to support early-stage life science, minority- and women-led startups in New York City. A change from previous award seasons, this year, two life science startup companies will each be awarded up to $250,000.

right

Deerfield Catalyst Request for Digital Health Proposals

Deadline: 
Friday, January 20, 2023 - 5:00pm

 


Deerfield Catalyst Request for Proposal

Advancing Innovative Digital Health Solutions Into Real-World Practice

right

National MS Society: Therapeutic Development Opportunities Addressing Nervous System Repair in Multiple Sclerosis

Deadline: 
Wednesday, January 4, 2023 - 5:00pm

 

 

The National MS Society is funding grants @ $800,000, for up to 2 years, for commercial R&D. Both for-profit companies and non-profit research centers are eligible. Applications are expected to demonstrate a potential path to commercialization.

The funder is inviting applications to establish research partnerships with the Society’s commercial development program, Fast Forward, LLC, to accelerate and support development of therapeutic strategies and biomarkers relevant to the Roadmap priority of Nervous System Repair in MS.

right

science2startup

Deadline: 
Monday, December 5, 2022 - 5:00pm

S2S is an invitation-only symposium for top scientists from leading research institutions to present their startup ideas and interact with leading investors and executives in the Boston biotechnology hub. 200+ anticipated attendees include entrepreneurs, biotech investors (Angels / VCs), pharma scouts, academic investigators, TTOs, etc. The symposium is a setting to showcase research from selected scientists. Submissions are reviewed by a senior Advisory Group. TTOs are also encouraged to submit 1-page proposals on behalf of researchers.

right

New York State Biodefense Commercialization Fund

Deadline: 
Thursday, October 6, 2022 - 5:00pm

Governor Hochul Announces Applications Open for Second Round of New York’s $40 Million Biodefense Commercialization Fund (Applications and Fund Guidelines Available 

Pages